These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3202569)

  • 41. Cholesteatoma in children: histopathologic findings in middle ear ossicles.
    Quaranta A; Bartoli R; Lozupone E; Resta L; Iurato S
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):296-8. PubMed ID: 8587786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
    Kurihara A; Toshima M; Yuasa R; Takasaka T
    Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cochlear fistula in chronic otitis media with cholesteatoma.
    Chao YH; Yun SH; Shin JO; Yoon JY; Lee DM
    Am J Otol; 1996 Jan; 17(1):15-8. PubMed ID: 8694120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipopolysaccharide concentration and bone resorption in cholesteatoma.
    Peek FA; Huisman MA; Berckmans RJ; Sturk A; Van Loon J; Grote JJ
    Otol Neurotol; 2003 Sep; 24(5):709-13. PubMed ID: 14501443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenic factors in bone resorption in cholesteatoma.
    Abramson M; Moriyama H; Huang CC
    Acta Otolaryngol; 1984; 97(5-6):437-42. PubMed ID: 6205536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathology of chronic inflammatory conduction disturbances].
    Müller E
    HNO; 1970 Apr; 18(4):112-5. PubMed ID: 5424365
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sound conduction chain of the middle ear in chronic epitympanal otitis. Scanning electronic microscope studies].
    Terrahe K; Fromme HG; Schulz J
    Z Laryngol Rhinol Otol; 1971 Jul; 50(7):548-56. PubMed ID: 5095015
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma.
    Yan SD; Huang CC
    Am J Otolaryngol; 1991; 12(2):83-9. PubMed ID: 1650149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiology of otosclerosis.
    Chole RA; McKenna M
    Otol Neurotol; 2001 Mar; 22(2):249-57. PubMed ID: 11300278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bone destruction in cholesteatoma--Raman spectroscopic analysis on the bone destruction].
    Fujita A
    Nihon Jibiinkoka Gakkai Kaiho; 1987 May; 90(5):706-16. PubMed ID: 3625385
    [No Abstract]   [Full Text] [Related]  

  • 51. Smith-McGuckin spot.
    Smith CW
    J R Soc Med; 1985 Jan; 78(1):18-26. PubMed ID: 4038519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic otitis media.
    Borkar DM
    Q Med Rev; 1980 Jan; 31(1):1-5, 7-17, 19-26. PubMed ID: 6997918
    [No Abstract]   [Full Text] [Related]  

  • 54. Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity.
    Karosi T; Csomor P; Szalmás A; Kónya J; Petkó M; Sziklai I
    Eur Arch Otorhinolaryngol; 2011 Mar; 268(3):357-65. PubMed ID: 20963600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current problems of meningoencephalic suppurations of otic origin].
    Obreja S; Boiko V; Mustaţă E
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1985; 30(3):161-8. PubMed ID: 2937095
    [No Abstract]   [Full Text] [Related]  

  • 56. Activated osteoclasts with CD51/61 expression in otosclerosis.
    Karosi T; Jókay I; Kónya J; Petkó M; Szabó LZ; Pytel J; Jóri J; Sziklai I
    Laryngoscope; 2006 Aug; 116(8):1478-84. PubMed ID: 16885757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric otolaryngology.
    Stool SE; Belafsky ML
    Curr Probl Pediatr; 1971 Dec; 2(2):1-51. PubMed ID: 5163978
    [No Abstract]   [Full Text] [Related]  

  • 59. Bone resorption in cholesteatoma: epithelial-mesenchymal cell interaction and collagenase production.
    Moriyama H; Honda Y; Huang CC; Abramson M
    Laryngoscope; 1987 Jul; 97(7 Pt 1):854-9. PubMed ID: 3037214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Latent mesoepitympanitis with a rare intracranial complication].
    Kalish SA; Kitsera AE
    Zh Ushn Nos Gorl Bolezn; 1973; 33(5):102-3. PubMed ID: 4788403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.